Fundz

Luminary Therapeutics, Inc. reported raising $5.22 Million in an initial SEC Form D filing, from an offering of $1.49 Million

PRIVATENov 14, 2019

Amount Raised

$5.22 Million

$5.22 Million sold, per SEC Form D (first sale Nov 14, 2019)

Round Type

Venture

MinneapolisBiotechnology

Quick answer

Luminary Therapeutics raised $5.22 Million in a funding round, dated November 14, 2019. Luminary Therapeutics is based in Minneapolis, Minnesota, United States.

How much did Luminary Therapeutics raise?
Luminary Therapeutics raised $5.22 Million in a funding round on November 14, 2019.
What does Luminary Therapeutics do?
Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells.
Where is Luminary Therapeutics based and how big is it?
Luminary Therapeutics is based in Minneapolis, Minnesota, United States. Fundz records about 10 employees.
Who are the decision-makers at Luminary Therapeutics?
Fundz holds 2 contacts at Luminary Therapeutics, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Luminary Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Zetagen Therapeutics raised $840K (Seed) on December 27, 2019.
  • Intervene Immune, Inc. raised $471K (Seed) on December 27, 2019.
  • Aurora Bio, Inc. raised $175K (Pre-Seed) on December 27, 2019.
  • Lakewood-Amedex, Inc. raised $456K (Seed) on December 26, 2019.
  • S2 Genomics raised $2.2M (Seed) on December 26, 2019.
  • Kinnate Biopharma raised $74M on December 23, 2019.

Who to call at Luminary Therapeutics, and when

A new round usually means Luminary Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Luminary Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Luminary Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Luminary Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Luminary Therapeutics

Location

1200 Washington Avenue South

Minneapolis, Minnesota, United States

About

Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is designed with 3 antigen receptors specifically designed to overcome antigen escape.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Luminary Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJeff L., Executive Officer, Director, PromoterSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Luminary Therapeutics's next move

See what Strategic adds

Luminary Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.